Morningstar

Minaris and Cell and Gene Therapy Catapult Announce Collaboration to Advance Delivery Methods for Cell and Gene Therapies

PHILADELPHIA and LONDON, Dec. 18, 2025 /PRNewswire/ -- Minaris, a global cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) and multimodality biosafety testing ...
Business Wire

ENCell Signs MOU with Cell Resources Corporation to Pave Way for Market Entry to Japan

- Inks a Memorandum of Understanding (MOU) with CRC, a member of Alfresa Group, a leading Japanese pharmaceutical distributor, to collaborate on cell and gene therapy (CGT). SEOUL, South ...
Morningstar

Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies

Cell and Gene Therapy Catapult’s Stevenage Manufacturing Innovation Centre Photo credit: Cell and Gene Therapy Catapult The first facility, housed within the Cell and Gene Therapy Catapult’s (CGT ...

청각장애인, ‘한국 수어’로 재난방송 시청 가능해진다

[헤럴드경제=손미정 기자] 청각장애인도 차별 없이 재난방송을 시청할 수 있게 된다. 방송미디어통신위원회(위원장 김종철)는 10일 청각장애인의 재난방송 접근권을 강화하기 위해 한국수어를 통해 재난방송 등을 실시하도록 하는 ‘방송통신발전 기본법 일부개정법률 공포안’이 국무회의에서 의결됐다고 밝혔다. 이번 개정은 권고사항에 불과했던 ‘재난방송 및 민방위 경보 방 ...
KTLA

Matica Biotechnology Emerges as the Go-To CDMO for Cell & Gene Therapy in 2025

COLLEGE STATION, Texas, Oct. 6, 2025 /PRNewswire/ --Matica Biotechnology, Inc., a U.S.-based Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies (CGT), ...
WFLA News Channel 8

Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs

TUSTIN, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient ...